Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical and medical decision-making, has expanded its strategic partnership with Databricks by launching the Atropos Evidence Agent Model Context Protocol (MCP) on the Databricks Marketplace. This milestone integration marks the next phase of a collaboration first established in June 2025, bringing automated, on-demand real-world evidence generation natively into the Databricks AI Playground and production-ready agents. By utilizing Model Context Protocol (MCP), the integration allows clinicians, researchers, and life sciences organizations to query complex clinical questions using natural language and safely surface insights from Alexandria®—the world’s largest body of medical evidence containing over 33 million precision Evidence Based Findings (pEBF™) directly within their governed Databricks workspace.
Also Read: Zifo Launches AI-Powered EHS Compliance Services Accelerator
This specialized capability bridges the critical gap between raw healthcare datasets and autonomous workflows, enabling organizations to fuel their customized AI applications with highly contextual, transparent, and clinically validated patient outcomes. Highlighting the infrastructure-level value of this launch for modern healthcare workloads, Dr. Brigham Hyde, CEO and co-founder of Atropos Health, stated: “Last year, we partnered with Databricks to bring our federated evidence network onto the Databricks platform. The launch of Atropos Evidence Agent MCP on Databricks Marketplace is the natural next step making that evidence directly accessible to the AI agents that healthcare and life sciences teams are building today.” Ultimately, by centralizing enterprise-grade data security and compliance within a single, open sharing environment, the combined solution empowers regulated life science and research teams to confidently scale production-level AI capabilities while maintaining complete data governance and entitlement controls.